Our Mission
GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care.
With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.
Latest News
GBS, Inc. receives approval to commence validation clinical study for rapid SARS-CoV-2 diagnostic test
NEW YORK APRIL 15, 2021 — GBS, Inc. (GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biologically Inspired Engineering at Harvard […]
With our world-first Biosensor Platform technology, GBS Inc. will develop and launch two urgently needed non-invasive, real-time diagnostic tests.
Behind the Technology
Meet the team at the Centre for Organic Electronics behind the biosensor technology.
A Member of The iQ Group Global
GBS Inc. is a member of The iQ Group Global, an award-winning consortium of companies that finds, funds and develops innovative bioscience intellectual property from world-class academic institutions to create life-changing medical innovations.
